Clinical trial
Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in…
NCT00487994 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00487994 |
|---|---|
| Title | Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia |
| Official title | A Double-Blind, Randomized, Parallel Group Study to Evaluate the Safety, Tolerability and Efficacy of Lapaquistat Acetate Alone or Coadministered With Atorvastatin in Subjects With Primary Dyslipidemia |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dyslipidemia |
| Intervention type | Drug |
| Interventions | Lapaquistat acetate, Lapaquistat acetate and atorvastatin, Atorvastatin |
| Enrollment | 2,130 |
| Start date | Nov 1, 2004 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jun 19, 2007 |
| Last update posted | May 24, 2012 |
| Countries | Argentina, Chile, Czechia, Estonia, Germany, Hungary, Latvia, Lithuania, Mexico, Netherlands, Peru, Poland and 5 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: